Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Two Types of GGE Biplots for Analyzing Multi‐Environment Trial Data

View through CrossRef
SA genotype main effect plus genotype × environment interaction (GGE) biplot graphically displays the genotypic main effect (G) and the genotype × environment interaction (GE) of the multienvironment trial (MET) data and facilitates visual evaluation of both the genotypes and the environments. This paper compares the merits of two types of GGE biplots in MET data analysis. The first type is constructed by the least squares solution of the sites regression model (SREG2), with the first two principal components as the primary and secondary effects, respectively. The second type is constructed by Man‐del's solution for sites regression as the primary effect and the first principal component extracted from the regression residual as the secondary effect (SREGM+1). Results indicate that both the SREG2 biplot and the SREGM+1 biplot are equally effective in displaying the “which‐won‐where” pattern of the MET data, although the SREG2 biplot explains slightly more GGE variation. The SREGM+1 biplot is more desirable, however, in that it always explicitly indicates the average yield and stability of the genotypes and the discriminating ability and representativeness of the test environments.
Title: Two Types of GGE Biplots for Analyzing Multi‐Environment Trial Data
Description:
SA genotype main effect plus genotype × environment interaction (GGE) biplot graphically displays the genotypic main effect (G) and the genotype × environment interaction (GE) of the multienvironment trial (MET) data and facilitates visual evaluation of both the genotypes and the environments.
This paper compares the merits of two types of GGE biplots in MET data analysis.
The first type is constructed by the least squares solution of the sites regression model (SREG2), with the first two principal components as the primary and secondary effects, respectively.
The second type is constructed by Man‐del's solution for sites regression as the primary effect and the first principal component extracted from the regression residual as the secondary effect (SREGM+1).
Results indicate that both the SREG2 biplot and the SREGM+1 biplot are equally effective in displaying the “which‐won‐where” pattern of the MET data, although the SREG2 biplot explains slightly more GGE variation.
The SREGM+1 biplot is more desirable, however, in that it always explicitly indicates the average yield and stability of the genotypes and the discriminating ability and representativeness of the test environments.

Related Results

International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
Unraveling the role of non-coding rare variants in epilepsy
Unraveling the role of non-coding rare variants in epilepsy
AbstractImportanceDespite the use of very large cohorts, the discovery of new variants has leveled off in recent years in epilepsy studies and consequently, most of the heritabilit...
Performance Evaluation of Different Sorghum Genotypes (Sorghum bicolour (L.) Moench) Using GGE Bi-plot Stability Analysis
Performance Evaluation of Different Sorghum Genotypes (Sorghum bicolour (L.) Moench) Using GGE Bi-plot Stability Analysis
Sorghum (Sorghum bicolor (L.) Moench) is an important essential cereal crop in Ethiopia. Conversely, its productivity is low due to numerous biotic and abiotic factors. There are d...
Identification of mega‐environments for grain sorghum in Brazil using GGE biplot methodology
Identification of mega‐environments for grain sorghum in Brazil using GGE biplot methodology
AbstractThe performance of genotypes in a wide range of environments can be affected by extensive genotype × environment (G × E) interactions, making the subdivision of the testing...
Abstract 6455: Investigating clinical trial eligibility criteria to improve MatchMiner trial matching
Abstract 6455: Investigating clinical trial eligibility criteria to improve MatchMiner trial matching
Abstract As the number of precision medicine (PM) trials and the volume of patient genomic data have grown, it has become challenging for clinicians and trial staff ...

Back to Top